Comments

Alkermes

Q: What sector and industry does Alkermes (ALKS) operate in?

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALKSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$35.50

0.000.00%

Pre-Market: 4:00 PM EDT

Alkermes (ALKS) Forecast

News Earnings Alkermes (ALKS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

Alkermes (NASDAQ:ALKS) Stock Quotes, Forecast and News Summary

Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	16.00 / 1.66M
Day Range	- - -
52 Wk Range	22.90 - 36.45
Market Cap	$5.77B
P/E Ratio	16.14
Dividend Yield	-
Exchange	NASDAQ
RSI	70
Short Interest	9.91%
Days to Cover	7.18

Recent News

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.

Piero Cingari

Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Alkermes Lags Q2 Earnings Estimates

Alkermes (NASDAQ: ALKS) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	16.00 / 1.66M
Day Range	- - -
52 Wk Range	22.90 - 36.45
Market Cap	$5.77B
P/E Ratio	16.14
Dividend Yield	-
Exchange	NASDAQ
RSI	70
Short Interest	9.91%
Days to Cover	7.18

About Alkermes plc

Sector

Health Care

Industry

Biotechnology

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies t...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Alkermes (ALKS) stock?

You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.

View our list of the best stock brokerages

Who are Alkermes (ALKS) competitors?

Other companies in Alkermes’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Alkermes (ALKS) stock?

Alkermes has a consensus price target of $35.19.

What is the current price for Alkermes (ALKS)?

The stock price for Alkermes (NASDAQ: ALKS) is $35.5 last updated February 20, 2025 at 4:00 PM EST.

Does Alkermes (ALKS) pay a dividend?

There are no upcoming dividends for Alkermes.

When is Alkermes (NASDAQ:ALKS) reporting earnings?

Alkermes’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Alkermes (ALKS) going to split?

There is no upcoming split for Alkermes.

What sector and industry does Alkermes (ALKS) operate in?

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.